Intrathecal Baclofen and Spasticity: What Do We Know and What Do We Need to Know?
- 1 August 1992
- journal article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 34 (8) , 739-745
- https://doi.org/10.1111/j.1469-8749.1992.tb11510.x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Continuous Intrathecal Baclofen Treatment of Severe Spasms in Two Children with Spinal‐cord InjuryDevelopmental Medicine and Child Neurology, 1992
- Chronic Intrathecal Baclofen Administration in Severe SpasticityStereotactic and Functional Neurosurgery, 1990
- Failure of Physostigmine in Treatment of Acute Severe Intrathecal Baclofen IntoxicationNew England Journal of Medicine, 1990
- Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Treatment of Spastic ParesisNew England Journal of Medicine, 1989
- Intrathecal Baclofen for Severe Spinal SpasticityNew England Journal of Medicine, 1989
- Short-term effects of intrathecal baclofen in spasticityExperimental Neurology, 1989
- Medtronic SynchroMed Drug Administration SystemAnnals of the New York Academy of Sciences, 1988
- Complications of baclofen overdosagePostgraduate Medical Journal, 1980
- Central cardiovascular and biochemical effects of baclofen in the conscious ratJournal of Pharmacy and Pharmacology, 1980